San Bernardino Urological Associates Medical Group Inc
1 clinical trials · Sponsor
◉ Watch San Bernardino Urological Associates Medical Group Inc
| Record | Firm | Date |
|---|---|---|
| A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer (NCT00220194) | San Bernardino Urological Associates Medical Group Inc | 2003-04-01 |
Track San Bernardino Urological Associates Medical Group Inc automatically
Every clearance here is in the API, with alerts when new ones post.